Oral Abstract Session:
132. Advances in Management of Bacteremia and Sepsis
Friday, October 6, 2017: 10:30 AM-12:00 PM
Room: 07AB

Tracks: Pediatric ID, Investigative ID, Adult ID


Moderators:  Helen W. Boucher, MD, FIDSA, Tufts Medical Center and Thomas Lodise, PharmD, PhD, Albany College of Pharmacy and the Health Sciences

Presentations:
10:30 AM
983
Doing the Same with Less: A Randomized, Multinational, Open-Label, Adjudicator-Blinded Trial of an Algorithm vs. Standard of Care to Determine Treatment Duration for Staphylococcal Bacteremia
Thomas L. Holland, MD; Helen W. Boucher, MD, FIDSA; Issam Raad, MD; Deverick J. Anderson, MD, MPH, FIDSA, FSHEA; Sara E. Cosgrove, MD, MS; Suzanne Aycock, MSN; John W. Baddley, MD; Shein-Chung Chow, PhD; Vivian H. Chu, MD; Paul P. Cook, MD; G. Ralph Corey, MD; Jennifer S. Daly, MD; Ray Y. Hachem, MD; Anne-Marie Chaftari, MD; James M. Horton, MD; Timothy C. Jenkins, MD; Jiezhun Gu, PhD; Donald P. Levine, MD; Jose M Miro, MD, PhD; Paul Riska, MD; Zachary A. Rubin, MD; Mark E. Rupp, MD; John Schrank Jr., MD; Matthew Sims, MD, PhD; Dannah Wray, MD; Marcus J. Zervos, MD; Vance G. Fowler Jr., MD
10:45 AM
984
Induced Hypothermia in Patients with Septic Shock and Ventilator-demanding Respiratory Failure
Theis Skovsgaard Itenov, MD, PhD; Maria Egede Johansen, MD, PhD; Morten Bestle, MD, PhD; Katrin Thormar, MD; Lars Hein, MD; Louise Gyldensted, MD; Anne Lindhardt, MD; Henrik Christensen, MD; Stine Estrup Damby, MD; Henrik Planck Pedersen, MD; Matthew Harmon, MD; Uday Kant Soni, MD; Silvia Perez-Protto, MD, PhD; Nikolaj Wesche, MD; Rasmus Ehrenfried Berthelsen, MD; Ulrik Skram, MD; Asger Petersen, MD, PhD; Thomas Mohr, MD, PhD; Tina Waldau, MD, PhD; Lone Museus Poulsen, MD; Ditte Strange, MD; Ole Christensen, MD; Nicole P Juffermans, MD, PhD; Daniel Sessler, MD, PhD; Else Tønnesen, MD, DMSc; Dennis Kristensen, MSc; Alessandro Cozzi-Lepri, PhD; Jens Lundgren, MD, DMSc, Professor; Jens Ulrik Stæhr Jensen, MD, PhD
11:00 AM
985
The Emperor’s New Clothes: Prospective Observational Evaluation of the Association between the Day 2 Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE)
Thomas P. Lodise Jr., PharmD, PhD; Susan L Rosenkranz, PhD; Matthew Finnemeyer, MPH; Jacqueline Huvane, PhD; Alenda Pereira, BS; Matthew Sims, MD, PhD; Marcus J. Zervos, MD; C Buddy Creech, MD, MPH, FPIDS; Pratish C. Patel, PharmD, BCPS; Michael Keefer, MD; Paul Riska, MD; Fernanda P. Silveira, MD, MS; Marc Scheetz, PharmD, MSc; Richard G. Wunderink, MD; Martin Rodriguez, MD, FIDSA; John Schrank, MD; Susan C. Bleasdale, MD; Sara Schultz, MD; Michelle Barron, MD; Ann Stapleton, MD, FIDSA; H Chambers, MD; Vance G. Fowler Jr., MD; Thomas L. Holland, MD
11:15 AM
986
Comparing the Outcomes of Adults with Enterobacteriaceae Bacteremia Receiving Short-Course versus Prolonged-Course Antibiotic Therapy
Darunee Chotiprasitsakul, MD, MPH; Jennifer H. Han, MD, MSCE; Anna T. Conley, BA; Sara E. Cosgrove, MD, MS; Anthony D. Harris, MD, MPH; Ebbing Lautenbach, MD, MPH, MSCE, FIDSA, FSHEA; Pranita Tamma, MD, MHS
11:30 AM
987
Infectious Disease Consultation Is Associated with Decreased Mortality with Enterococcal Bloodstream Infections
Rachael A. Lee, MD; Daniel Vo, MD; Joanna Zurko, MD; Russell Griffin, PhD; J. Martin Rodriguez, MD; Bernard Camins, MD, MSc

CME Credits: No CME credit is offered for this session.


See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.